Folomeev M, Dougados M, Beaune J, Kouyoumdjian J C, Nahoul K, Amor B, Alekberova Z
Department of Rheumoendocrinology, Institute of Rheumatology, Moscow, Russia.
Lupus. 1992 May;1(3):191-5. doi: 10.1177/096120339200100312.
Clinical observations and experimental data suggest that sex hormones influence the development of systemic lupus erythematosus (SLE). An imbalance between androgen and estrogen plasma levels may suggest an abnormality in the aromatase activity involved in estradiol synthesis. Aromatase activity in skin and subcutaneous tissue and plasma sex-hormone levels (testosterone, androstenedione, estrone, estradiol, dehydrosterone sulfate, cortisol) were measured in 15 SLE patients (nine female, six male) who had never received corticosteroid treatment and in eight (four female, four male) healthy control subjects. There was a tendency toward an increase in aromatase activity in SLE patients when compared to control subjects. Among SLE patients the aromatase activity varied inversely with disease activity. Patients with SLE had decreased androgen and increased estrogen levels. Aromatase activity in SLE patients had significant direct correlation with estrogen levels. These data suggest that abnormal regulation of aromatase activity may partially explain the abnormalities of estrogen synthesis in SLE.
临床观察和实验数据表明,性激素会影响系统性红斑狼疮(SLE)的发展。雄激素和雌激素血浆水平之间的失衡可能表明参与雌二醇合成的芳香化酶活性存在异常。对15名从未接受过皮质类固醇治疗的SLE患者(9名女性,6名男性)和8名(4名女性,4名男性)健康对照者测量了皮肤和皮下组织中的芳香化酶活性以及血浆性激素水平(睾酮、雄烯二酮、雌酮、雌二醇、硫酸脱氢表雄酮、皮质醇)。与对照者相比,SLE患者的芳香化酶活性有增加的趋势。在SLE患者中,芳香化酶活性与疾病活动呈负相关。SLE患者的雄激素水平降低,雌激素水平升高。SLE患者的芳香化酶活性与雌激素水平呈显著正相关。这些数据表明,芳香化酶活性的异常调节可能部分解释了SLE中雌激素合成的异常。